XML 50 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Intangible Assets - Additional Information (Detail) - USD ($)
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Finite Lived Intangible Assets [Line Items]    
Amortization expense $ 425,107 $ 425,107
Amortization of license agreements remainder of fiscal year 2019 1,275,322  
Amortization of license agreements in 2020 1,700,429  
Amortization of license agreements in 2021 1,700,429  
Amortization of license agreements in 2022 1,700,429  
Amortization of license agreements in 2023 1,700,429  
Amortization of license agreements, thereafter $ 10,261,865  
Novartis | Licensing Agreement    
Finite Lived Intangible Assets [Line Items]    
Amortization period of intangible assets 21 years  
Finite-lived intangible assets, accumulated amortization $ 568,887  
Novartis | Patents    
Finite Lived Intangible Assets [Line Items]    
Amortization period of intangible assets 14 years  
Finite-lived intangible assets, accumulated amortization $ 5,949,425